Real-world data suggest that, although guideline-concordant care is on the rise, many US patients with mHSPC may not receive it.

Dr. Guru P Sonpavde discusses updated data from studies like EV-302 and CheckMate 274 for patients with urothelial cancer at the 2025 ASCO GU meeting.

As key members of the Johns Hopkins Department of Genetic Medicine, genetic counselors help patients with rare diseases ...

The Ballard Clinic sits across the street from the Greyhound bus station in the hollowed-out downtown of Jackson, Tenn., a small city about an hour from Memphis. After Dr. Thomas Ballard III took ...

On top of the flu infection itself, doctors say they’re seeing large numbers of patients with some of its most devastating complications. In children, specialists say they’re seeing more than ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

A urologist and surgeon, he treats all kinds of conditions, from complex kidney stones to incontinence to urologic cancers.

Market OverviewThe Global Hormone Replacement Therapy Market is valued at USD 22.6 Billion in 2023 and is projected to reach ...

Anita Osborn outlines the best ways to start and maintain a patient support initiative in an increasingly complex health environment. As the healthcare environment continues to evolve, patient ...

Aaron Baltaytis, a Northwestern University varsity swimmer, recently received a devastating diagnosis of testicular cancer but was motivated by his team and coaches to continue his rehabilitation ...

GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Miguel Muniz discussing outcomes for 177 Lu-PSMA-617 with and without concurrent use of androgen receptor pathway ...

Bayer's venerable testosterone replacement product for men with hypogonadism – Nebido – is being sold to Grünenthal as the group continues a revamp of its healthcare business. Grünenthal is ...